{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:42:01Z","timestamp":1788856921902,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019033","name":"Key Research and Development Program of Liaoning Province","doi-asserted-by":"publisher","award":["2024JH2\/102500046"],"award-info":[{"award-number":["2024JH2\/102500046"]}],"id":[{"id":"10.13039\/501100019033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08460-z","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T16:46:21Z","timestamp":1781369181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cervical cancer screening policy inequality worldwide: a systematic review of disparities in access and implementation"],"prefix":"10.1186","volume":"24","author":[{"given":"Ruijun","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1062-1295","authenticated-orcid":false,"given":"Bo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"8460_CR1","unstructured":"Cervical cancer [Internet]. [cited 2025 July 7]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer. Accessed 7 July 2025."},{"key":"8460_CR2","unstructured":"Global strategy to. accelerate the elimination of cervical cancer as a public health problem [Internet]. [cited 2025 July 7]. https:\/\/www.who.int\/publications\/i\/item\/9789240014107. Accessed 7 July 2025."},{"key":"8460_CR3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fphar.2019.00484","volume":"10","author":"T \u0160arenac","year":"2019","unstructured":"\u0160arenac T, Mikov M. Cervical cancer, different treatments and importance of bile acids as therapeutic agents in this disease. Front Pharmacol. 2019;10:484. https:\/\/doi.org\/10.3389\/fphar.2019.00484.","journal-title":"Front Pharmacol"},{"key":"8460_CR4","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1002\/ijc.31212","volume":"142","author":"M Gultekin","year":"2018","unstructured":"Gultekin M, Zayifoglu Karaca M, Kucukyildiz I, Dundar S, Boztas G, Semra Turan H, et al. Initial results of population based cervical cancer screening program using HPV testing in one million urkish women. Intl J Cancer. 2018;142:1952\u20138. https:\/\/doi.org\/10.1002\/ijc.31212.","journal-title":"Intl J Cancer"},{"key":"8460_CR5","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/s41591-024-03014-6","volume":"30","author":"L Schreiberhuber","year":"2024","unstructured":"Schreiberhuber L, Barrett JE, Wang J, Redl E, Herzog C, Vavourakis CD, et al. Cervical cancer screening using DNA methylation triage in a real-world population. Nat Med. 2024;30:2251\u20137. https:\/\/doi.org\/10.1038\/s41591-024-03014-6.","journal-title":"Nat Med"},{"key":"8460_CR6","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.lana.2021.100084","volume":"5","author":"JC Teixeira","year":"2021","unstructured":"Teixeira JC, Vale DB, Campos CS, Bragan\u00e7a JF, Discacciati MG, Zeferino LC. Organization of cervical cancer screening with DNA\u2013HPV testing impact on early\u2013stage cancer detection: A population\u2013based demonstration study in a brazilian city. Lancet Reg Health Am. 2021;5:100084. https:\/\/doi.org\/10.1016\/j.lana.2021.100084.","journal-title":"Lancet Reg Health Am"},{"key":"8460_CR7","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","volume":"360","author":"R Sankaranarayanan","year":"2009","unstructured":"Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360:1385\u201394. https:\/\/doi.org\/10.1056\/NEJMoa0808516.","journal-title":"N Engl J Med"},{"key":"8460_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/s0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, Tunesi S, Snijders PJF, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four european randomised controlled trials. Lancet Elsevier BV. 2014;383:524\u201332. https:\/\/doi.org\/10.1016\/s0140-6736(13)62218-7.","journal-title":"Lancet Elsevier BV"},{"key":"8460_CR9","doi-asserted-by":"publisher","unstructured":"Liang LA, Einzmann T, Franzen A, Schwarzer K, Schauberger G, Schriefer D, et al. Cervical cancer screening: Comparison of conventional pap smear test, liquid-based cytology, and human papillomavirus testing as stand-alone or cotesting strategies. Cancer Epidemiol. Biomarkers Prev.; 2021;30:474\u201384. https:\/\/doi.org\/10.1158\/1055-9965.epi-20-1003.","DOI":"10.1158\/1055-9965.epi-20-1003"},{"key":"8460_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/jrh.12202","volume":"33","author":"YJ McDonald","year":"2017","unstructured":"McDonald YJ, Goldberg DW, Scarinci IC, Castle PE, Cuzick J, Robertson M, et al. Health service accessibility and risk in cervical cancer prevention: Comparing rural versus nonrural residence in new mexico. J Rural Health. 2017;33:382\u201392. https:\/\/doi.org\/10.1111\/jrh.12202.","journal-title":"J Rural Health"},{"key":"8460_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.2971","author":"JR Montealegre","year":"2025","unstructured":"Montealegre JR, Hilsenbeck SG, Bulsara S, Parker SL, Amboree TL, Anderson ML, et al. Self-collection for cervical cancer screening in a safety-net setting: The PRESTIS randomized clinical trial. JAMA Intern Med [Internet]. 2025. https:\/\/doi.org\/10.1001\/jamainternmed.2025.2971. [cited 2025 July 7].","journal-title":"JAMA Intern Med [Internet]"},{"key":"8460_CR12","doi-asserted-by":"publisher","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: Use of dual-stain cytology to triage women after a positive test for human papillomavirus (HPV). Web annex C. Evidence-to-decision framework for dual-stain cytology to triage women after a positive test for human papillomavirus (HPV) [Internet]. World Health Organization; 2024. [cited 2025 July 7]. https:\/\/doi.org\/10.2471\/B09020.","DOI":"10.2471\/B09020"},{"key":"8460_CR13","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","volume":"10","author":"L Bruni","year":"2022","unstructured":"Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: A review and synthetic analysis. Lancet Global Health. 2022;10:e1115\u201327. https:\/\/doi.org\/10.1016\/S2214-109X(22)00241-8.","journal-title":"Lancet Global Health"},{"key":"8460_CR14","unstructured":"THE NATIONAL CERVICAL CANCER PREVENTION AND CONTROL STRATEGIC PLAN [Internet]. [cited 2025 July 7]. https:\/\/platform.who.int\/docs\/default-source\/mca-documents\/policy-documents\/plan-strategy\/UGA-RH-47-01-PLAN-STRATEGY-2018-eng-Strategic-PlanII-2018-2023-Uganda.pdf. Accessed 7 July 2025."},{"key":"8460_CR15","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.3390\/cancers16203475","volume":"16","author":"Q Huang","year":"2024","unstructured":"Huang Q, Tan L-Y. Exploring factors influencing cervical cancer screening participation among singaporean women: A social ecological approach. Cancers. 2024;16:3475. https:\/\/doi.org\/10.3390\/cancers16203475.","journal-title":"Cancers"},{"key":"8460_CR16","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s41591-023-02315-6","volume":"29","author":"L Zhang","year":"2023","unstructured":"Zhang L, Mosquera I, Lucas E, Rol ML, Carvalho AL, Basu P, et al. CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs. Nat Med. 2023;29:1135\u201345. https:\/\/doi.org\/10.1038\/s41591-023-02315-6.","journal-title":"Nat Med"},{"key":"8460_CR17","unstructured":"Test coverage \u2013. NordScreen [Internet]. [cited 2025 July 7]. https:\/\/nordscreen.org\/analysis\/cervical-cancer-screening\/test-coverage\/. Accessed 7 July 2025."},{"key":"8460_CR18","unstructured":"C D. 2023 NHIS questionnaires, datasets, and documentation [Internet]. National Health Interview Survey. 2024 [cited 2025 July 7]. https:\/\/www.cdc.gov\/nchs\/nhis\/documentation\/2023-nhis.html. Accessed 7 July 2025."},{"key":"8460_CR19","unstructured":"canscreen5 [Internet]. [cited 2025 July 8]. https:\/\/canscreen5.iarc.fr. Accessed 8 July 2025."},{"key":"8460_CR20","unstructured":"Nations U. Human development index [Internet]. Human Development Reports. United Nations. https:\/\/hdr.undp.org\/data-center\/human-development-index. Accessed 8 July 2025."},{"key":"8460_CR21","unstructured":"World bank country. and lending groups \u2013 world bank data help desk [Internet]. [cited 2025 July 8]. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519. Accessed 8 July 2025."},{"key":"8460_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ijgo.15600","volume":"166","author":"P Descamps","year":"2024","unstructured":"Descamps P, Dixon S, Bosch Jose FX, Kyrgiou M, Monsonego J, Neisingh O, et al. Turning the tide\u2014recommendations to increase cervical cancer screening among women who are underscreened. Int J Gynecol Obstet. 2024;166:3\u201321. https:\/\/doi.org\/10.1002\/ijgo.15600.","journal-title":"Int J Gynecol Obstet"},{"key":"8460_CR23","doi-asserted-by":"publisher","first-page":"e65555","DOI":"10.7759\/cureus.65555","volume":"16","author":"O Farajimakin","year":"2024","unstructured":"Farajimakin O. Barriers to cervical cancer screening: A systematic review. Cureus. 2024;16:e65555. https:\/\/doi.org\/10.7759\/cureus.65555.","journal-title":"Cureus"},{"key":"8460_CR24","doi-asserted-by":"publisher","unstructured":"Brisson M. Impact of HPV vaccination and cervical screening on cervical cancer elimination: A comparative modelling analysis in 78 low-income and lower-middle-income countries. https:\/\/doi.org\/10.1016\/S0140-6736(20)30068-4.","DOI":"10.1016\/S0140-6736(20)30068-4"},{"key":"8460_CR25","doi-asserted-by":"publisher","first-page":"106237","DOI":"10.1016\/j.ypmed.2020.106237","volume":"144","author":"M Pi\u00f1eros","year":"2021","unstructured":"Pi\u00f1eros M, Saraiya M, Baussano I, Bonjour M, Chao A, Bray F. The role and utility of population-based cancer registries in cervical cancer surveillance and control. Prev Med. 2021;144:106237. https:\/\/doi.org\/10.1016\/j.ypmed.2020.106237.","journal-title":"Prev Med"},{"key":"8460_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12889-024-17842-1","volume":"24","author":"F Mantula","year":"2024","unstructured":"Mantula F, Toefy Y, Sewram V. Barriers to cervical cancer screening in africa: A systematic review. BMC Public Health. 2024;24:525. https:\/\/doi.org\/10.1186\/s12889-024-17842-1.","journal-title":"BMC Public Health"},{"key":"8460_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12939-020-01275-4","volume":"19","author":"P Marques","year":"2020","unstructured":"Marques P, Nunes M, Antunes Mda, Heleno L, Dias B. Factors associated with cervical cancer screening participation among migrant women in europe: A scoping review. Int J Equity Health. 2020;19:160. https:\/\/doi.org\/10.1186\/s12939-020-01275-4.","journal-title":"Int J Equity Health"},{"key":"8460_CR28","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.1188\/17.ONF.E20-E33","volume":"44","author":"S Abboud","year":"2017","unstructured":"Abboud S, De Penning E, Brawner BM, Menon U, Glanz K, Sommers MS. Cervical cancer screening among arab women in the united states: An integrative review. Oncol Nurs Forum. 2017;44:E20\u201333. https:\/\/doi.org\/10.1188\/17.ONF.E20-E33.","journal-title":"Oncol Nurs Forum"},{"key":"8460_CR29","unstructured":"Cervical Cancer Screening in Canada [Internet]. [cited 2025 July 8]. https:\/\/www.jogc.com\/action\/showPdf?pii=S1701-2163%2819%2930739-X. Accessed 8 July 2025."},{"key":"8460_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.2023.13174","volume":"330","author":"RB Perkins","year":"2023","unstructured":"Perkins RB, Wentzensen N, Guido RS, Schiffman M. Cervical cancer screening: A review. JAMA Am Med Association (AMA). 2023;330:547. https:\/\/doi.org\/10.1001\/jama.2023.13174.","journal-title":"JAMA Am Med Association (AMA)"},{"key":"8460_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n280","author":"C Gilham","year":"2021","unstructured":"Gilham C, Crosbie EJ, Peto J. Cervical cancer screening in older women. BMJ BMJ. 2021. https:\/\/doi.org\/10.1136\/bmj.n280. n280.","journal-title":"BMJ BMJ"},{"key":"8460_CR32","unstructured":"Target product profiles. for human papillomavirus screening tests to detect cervical pre-cancer and cancer [Internet]. [cited 2025 July 8]. https:\/\/iris.who.int\/bitstream\/handle\/10665\/379099\/9789240100275-eng.pdf. Accessed 8 July 2025."},{"key":"8460_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/01.OGX.0000079632.98372.26","volume":"58","author":"L Gaffikin","year":"2003","unstructured":"Gaffikin L, Lauterbach M, Blumenthal PD. Performance of visual inspection with acetic acid for cervical cancer screening: A qualitative summary of evidence to date. Obstet Gynecol Surv. 2003;58:543\u201350. https:\/\/doi.org\/10.1097\/01.OGX.0000079632.98372.26.","journal-title":"Obstet Gynecol Surv"},{"key":"8460_CR34","doi-asserted-by":"publisher","first-page":"e037955","DOI":"10.1136\/bmjopen-2020-037955","volume":"10","author":"K Taghavi","year":"2020","unstructured":"Taghavi K, Moono M, Mwanahamuntu M, Basu P, Limacher A, Tembo T, et al. Screening test accuracy to improve detection of precancerous lesions of the cervix in women living with HIV: A study protocol. BMJ Open. 2020;10:e037955. https:\/\/doi.org\/10.1136\/bmjopen-2020-037955.","journal-title":"BMJ Open"},{"key":"8460_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/LGT.0b013e31824ca9d5","volume":"16","author":"D Saslow","year":"2012","unstructured":"Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, et al. American cancer society, American society for colposcopy and cervical pathology, and american society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis. 2012;16:175\u2013204. https:\/\/doi.org\/10.1097\/LGT.0b013e31824ca9d5.","journal-title":"J Low Genit Tract Dis"},{"key":"8460_CR36","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, Tunesi S, Snijders PJF, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four european randomised controlled trials. Lancet. 2014;383:524\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(13)62218-7.","journal-title":"Lancet"},{"key":"8460_CR37","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.2147\/RMHP.S296914","volume":"15","author":"KS Okunade","year":"2022","unstructured":"Okunade KS, Adejimi AA, John-Olabode SO, Oshodi YA, Oluwole AA. An overview of HPV screening tests to improve access to cervical cancer screening amongst underserved populations: From development to implementation. Risk Manag Healthc Policy. 2022;15:1823\u201330. https:\/\/doi.org\/10.2147\/RMHP.S296914.","journal-title":"Risk Manag Healthc Policy"},{"key":"8460_CR38","doi-asserted-by":"publisher","first-page":"101675","DOI":"10.1016\/j.pmedr.2021.101675","volume":"25","author":"L Bergengren","year":"2021","unstructured":"Bergengren L, Ryen L, Flodstr\u00f6m C, Fadl H, Udumyen R, Karlsson MG, et al. Effectiveness and costs of an implemented primary HPV cervical screening programme in sweden \u2013 a population based cohort study. Prev Med Rep. 2021;25:101675. https:\/\/doi.org\/10.1016\/j.pmedr.2021.101675.","journal-title":"Prev Med Rep"},{"key":"8460_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12992-022-00890-w","volume":"18","author":"W Zhang","year":"2022","unstructured":"Zhang W, Gao K, Fowkes FJI, Adeloye D, Rudan I, Song P, et al. Associated factors and global adherence of cervical cancer screening in 2019: A systematic analysis and modelling study. Global Health. 2022;18:101. https:\/\/doi.org\/10.1186\/s12992-022-00890-w.","journal-title":"Global Health"},{"key":"8460_CR40","doi-asserted-by":"publisher","first-page":"106322","DOI":"10.1016\/j.ypmed.2020.106322","volume":"144","author":"PE Gravitt","year":"2021","unstructured":"Gravitt PE, Silver MI, Hussey HM, Arrossi S, Huchko M, Jeronimo J, et al. Achieving equity in cervical cancer screening in low- and middle-income countries (LMICs): Strengthening health systems using a systems thinking approach. Prev Med. 2021;144:106322. https:\/\/doi.org\/10.1016\/j.ypmed.2020.106322.","journal-title":"Prev Med"},{"key":"8460_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fonc.2016.00160","volume":"6","author":"TC Randall","year":"2016","unstructured":"Randall TC, Ghebre R. Challenges in prevention and care delivery for women with cervical cancer in sub-saharan africa. Front Oncol. 2016;6:160. https:\/\/doi.org\/10.3389\/fonc.2016.00160.","journal-title":"Front Oncol"},{"key":"8460_CR42","doi-asserted-by":"publisher","first-page":"e087792","DOI":"10.1136\/bmjopen-2024-087792","volume":"15","author":"N Dereje","year":"2025","unstructured":"Dereje N, Addissie A, Worku A, Assefa M, Gebremariam A, Kantelhardt EJ, et al. Barriers to early diagnosis and treatment of cervical cancer in addis ababa, ethiopia: Qualitative study. BMJ Open. 2025;15:e087792. https:\/\/doi.org\/10.1136\/bmjopen-2024-087792.","journal-title":"BMJ Open"},{"key":"8460_CR43","doi-asserted-by":"publisher","first-page":"106400","DOI":"10.1016\/j.ypmed.2020.106400","volume":"144","author":"LN Fuzzell","year":"2021","unstructured":"Fuzzell LN, Perkins RB, Christy SM, Lake PW, Vadaparampil ST. Cervical cancer screening in the united states: Challenges and potential solutions for underscreened groups. Prev Med. 2021;144:106400. https:\/\/doi.org\/10.1016\/j.ypmed.2020.106400.","journal-title":"Prev Med"},{"key":"8460_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ypmed.2015.09.011","volume":"81","author":"G Damiani","year":"2015","unstructured":"Damiani G, Basso D, Acampora A, Bianchi CBNA, Silvestrini G, Frisicale EM, et al. The impact of level of education on adherence to breast and cervical cancer screening: Evidence from a systematic review and meta-analysis. Prev Med. 2015;81:281\u20139. https:\/\/doi.org\/10.1016\/j.ypmed.2015.09.011.","journal-title":"Prev Med"},{"key":"8460_CR45","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12905-025-03841-w","volume":"25","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Fan Z, Wang J, Guan B, Zhou F, Tang Z, et al. HPV vaccination, screening disparities, and the shifting landscape of cervical cancer burden: A global analysis of trends, inequalities, and policy implications. BMC Women\u2019s Health. 2025;25:285. https:\/\/doi.org\/10.1186\/s12905-025-03841-w.","journal-title":"BMC Women\u2019s Health"},{"key":"8460_CR46","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2019","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Global Health. 2019;8:e191. https:\/\/doi.org\/10.1016\/S2214-109X(19)30482-6.","journal-title":"Lancet Global Health"},{"key":"8460_CR47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/0969141318767471","volume":"25","author":"KF Bennett","year":"2018","unstructured":"Bennett KF, Waller J, Chorley AJ, Ferrer RA, Haddrell JB, Marlow LA. Barriers to cervical screening and interest in self-sampling among women who actively decline screening. J Med Screen. 2018;25:211\u20137. https:\/\/doi.org\/10.1177\/0969141318767471.","journal-title":"J Med Screen"},{"key":"8460_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13027-024-00614-2","volume":"19","author":"R Chen","year":"2024","unstructured":"Chen R, Li Y, Li X, Wang X, L\u00fc W, Fu Y. Age-specific 3-year risk of cervical precancer among HPV-positive women attending screening: A post hoc analysis from a retrospective cohort. Infect Agent Cancer. 2024;19:53. https:\/\/doi.org\/10.1186\/s13027-024-00614-2.","journal-title":"Infect Agent Cancer"},{"key":"8460_CR49","doi-asserted-by":"publisher","unstructured":"Oscarsson MG, Wijma BE, Benzein EG. \u2018I do not need to\u2026 I do not want to\u2026 I do not give it priority\u2026 \u2019\u2013 why women choose not to attend cervical cancer screening. Health Expect. 2008;11:26\u201334. https:\/\/doi.org\/10.1111\/j.1369-7625.2007.00478.x..","DOI":"10.1111\/j.1369-7625.2007.00478.x."},{"key":"8460_CR50","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/pon.1270","volume":"17","author":"K Blomberg","year":"2008","unstructured":"Blomberg K, Ternestedt B, T\u00f6rnberg S, Tishelman C. How do women who choose not to participate in population-based cervical cancer screening reason about their decision? Psycho-Oncology Wiley. 2008;17:561\u20139. https:\/\/doi.org\/10.1002\/pon.1270.","journal-title":"Psycho-Oncology Wiley"},{"key":"8460_CR51","doi-asserted-by":"publisher","first-page":"e250479","DOI":"10.1001\/jamanetworkopen.2025.0479","volume":"8","author":"SL Kulasingam","year":"2025","unstructured":"Kulasingam SL, de Kok IMCM, Mehta A, Jansen EEL, Regan MC, Killen JW, et al. Estimated cancer risk in females who meet the criteria to exit cervical cancer screening. JAMA Netw Open. 2025;8:e250479. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.0479.","journal-title":"JAMA Netw Open"},{"key":"8460_CR52","doi-asserted-by":"publisher","first-page":"e082145","DOI":"10.1136\/bmjopen-2023-082145","volume":"15","author":"HT Bui","year":"2025","unstructured":"Bui HT, Pham VNH, Vu TH. Cervical cancer screening by cotesting method for vietnamese women 25\u201355 years old: A cost-effectiveness analysis. BMJ Open. 2025;15:e082145. https:\/\/doi.org\/10.1136\/bmjopen-2023-082145.","journal-title":"BMJ Open"},{"key":"8460_CR53","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/sj.bjc.6605974","volume":"103","author":"IH-I Chow","year":"2010","unstructured":"Chow IH-I, Tang C-H, You S-L, Liao C-H, Chu T-Y, Chen C-J, et al. Cost-effectiveness analysis of human papillomavirus DNA testing and pap smear for cervical cancer screening in a publicly financed health-care system. Br J Cancer. 2010;103:1773\u201382. https:\/\/doi.org\/10.1038\/sj.bjc.6605974.","journal-title":"Br J Cancer"},{"key":"8460_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12916-023-02840-8","volume":"21","author":"X-L Zhao","year":"2023","unstructured":"Zhao X-L, Zhao S, Xia C-F, Hu S-Y, Duan X-Z, Liu Z-H, et al. Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: A modeling study. BMC Med. 2023;21:149. https:\/\/doi.org\/10.1186\/s12916-023-02840-8.","journal-title":"BMC Med"},{"key":"8460_CR55","doi-asserted-by":"publisher","first-page":"321","DOI":"10.46234\/ccdcw2025.052","volume":"7","author":"M Zhang","year":"2025","unstructured":"Zhang M, Wang L, Zhang X, Li C, Zhao Z, Yu M, et al. Cervical cancer screening rates among Chinese women \u2014 China, 2023\u20132024. China CDC Wkly. 2025;7:321\u20136. https:\/\/doi.org\/10.46234\/ccdcw2025.052.","journal-title":"China CDC Wkly"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08460-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08460-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08460-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:02:01Z","timestamp":1787580121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08460-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8460"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08460-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1083"}}